Skip to main content
. 2020 Dec 10;8:614354. doi: 10.3389/fped.2020.614354

Table 2A.

Basic laboratory findings.

JIA patients treated with MTX JIA patients treated with MTX/ADA Healthy controls Significance (p-value)
ESR (mm/hour) 12.00 ± 7.82 10.85 ± 6.63 8.68 ± 5.88 0.295
0.509
0.851
CRP (mg/l) 0.85 ± 1.67 1.03 ± 2.13 1.09 ± 1.68 0.923
0.992
0.957
Leukocyte (G/l) 6.92 ± 2.38 7.22 ± 1.47 6.77 ± 1.35 0.959
0.630
0.846
ANC (G/l) 3.94 ± 1.57 3.71 ± 1.03 3.69 ± 1.14 0.803
0.999
0.814
Monocyte (%) 0.33 ± 0.18 0.38 ± 0.12 0.33 ± 0.84 0.988
0.429
0.392
Thrombocyte (G/l) 304.06 ± 62.47 295.04± 58.78 302.05 ± 89.23 0.996
0.939
0.917

Data aremeans ± standard deviation. p1 = MTX and control, p2 = MTX/ADA and control, p3 = MTX and MTX/ADA.